tiprankstipranks
Trending News
More News >
Ascentage Pharma Group International (HK:6855)
:6855
Hong Kong Market

Ascentage Pharma Group International (6855) Financial Statements

Compare
1 Followers

Ascentage Pharma Group International Financial Overview

Ascentage Pharma Group International's market cap is currently HK$21.54B. The company's EPS TTM is HK$-1.456; its P/E ratio is ―; Ascentage Pharma Group International is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 980.65M¥ 221.98M¥ 209.71M¥ 27.91M¥ 12.45M
Gross Profit¥ 951.57M¥ 191.44M¥ 187.71M¥ 24.58M¥ 10.48M
Operating Income¥ -378.80M¥ -891.99M¥ -883.41M¥ -933.17M¥ -684.43M
EBITDA¥ -299.63M¥ -743.61M¥ -835.99M¥ -915.99M¥ -641.77M
Net Income¥ -405.43M¥ -925.64M¥ -882.92M¥ -782.42M¥ -677.61M
Balance Sheet
Cash & Short-Term Investments¥ 1.26B¥ 1.10B¥ 1.50B¥ 1.75B¥ 1.03B
Total Assets¥ 2.62B¥ 2.50B¥ 2.83B¥ 2.94B¥ 1.73B
Total Debt¥ 1.67B¥ 1.80B¥ 1.79B¥ 1.08B¥ 529.70M
Net Debt¥ 407.29M¥ 726.30M¥ 300.49M¥ -659.53M¥ -494.70M
Total Liabilities¥ 2.34B¥ 2.43B¥ 2.42B¥ 1.71B¥ 884.42M
Stockholders' Equity¥ 264.19M¥ 60.42M¥ 408.66M¥ 1.23B¥ 846.62M
Cash Flow
Free Cash Flow¥ -135.65M¥ -782.92M¥ -857.20M¥ -1.04B¥ -859.88M
Operating Cash Flow¥ -111.36M¥ -726.08M¥ -653.91M¥ -604.68M¥ -609.96M
Investing Cash Flow¥ -362.04M¥ 21.92M¥ -384.61M¥ -466.52M¥ -107.37M
Financing Cash Flow¥ 314.77M¥ 368.75M¥ 619.27M¥ 1.78B¥ 1.04B
Currency in CNY

Ascentage Pharma Group International Earnings and Revenue History

Ascentage Pharma Group International Debt to Assets

Ascentage Pharma Group International Cash Flow

Ascentage Pharma Group International Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis